Medacta Group SA

SWX:MOVE 株式レポート

時価総額：CHF 3.0b

Medacta Group マネジメント

マネジメント 基準チェック /34

現在、CEO に関する十分な情報がありません。

主要情報

Francesco Siccardi

最高経営責任者

€2.0m

報酬総額

CEO給与比率19.61%
CEO在任期間7yrs
CEOの所有権n/a
経営陣の平均在職期間12.3yrs
取締役会の平均在任期間6.8yrs

経営陣の近況

Medacta Group SA's (VTX:MOVE) CEO Compensation Looks Acceptable To Us And Here's Why

May 01
Medacta Group SA's (VTX:MOVE) CEO Compensation Looks Acceptable To Us And Here's Why

We Discuss Why Medacta Group SA's (VTX:MOVE) CEO Will Find It Hard To Get A Pay Rise From Shareholders This Year

May 01
We Discuss Why Medacta Group SA's (VTX:MOVE) CEO Will Find It Hard To Get A Pay Rise From Shareholders This Year

Recent updates

Medacta Group (VTX:MOVE) Is Looking To Continue Growing Its Returns On Capital

Nov 08
Medacta Group (VTX:MOVE) Is Looking To Continue Growing Its Returns On Capital

Does Medacta Group (VTX:MOVE) Have A Healthy Balance Sheet?

Oct 21
Does Medacta Group (VTX:MOVE) Have A Healthy Balance Sheet?

Investor Optimism Abounds Medacta Group SA (VTX:MOVE) But Growth Is Lacking

Oct 01
Investor Optimism Abounds Medacta Group SA (VTX:MOVE) But Growth Is Lacking

Medacta Group's (VTX:MOVE) Solid Profits Have Weak Fundamentals

Sep 13
Medacta Group's (VTX:MOVE) Solid Profits Have Weak Fundamentals

Should You Investigate Medacta Group SA (VTX:MOVE) At CHF150?

Sep 12
Should You Investigate Medacta Group SA (VTX:MOVE) At CHF150?

Estimating The Fair Value Of Medacta Group SA (VTX:MOVE)

Aug 29
Estimating The Fair Value Of Medacta Group SA (VTX:MOVE)

Medacta Group (VTX:MOVE) Has Some Way To Go To Become A Multi-Bagger

Aug 01
Medacta Group (VTX:MOVE) Has Some Way To Go To Become A Multi-Bagger

Do Medacta Group's (VTX:MOVE) Earnings Warrant Your Attention?

Jun 24
Do Medacta Group's (VTX:MOVE) Earnings Warrant Your Attention?

What Does Medacta Group SA's (VTX:MOVE) Share Price Indicate?

May 24
What Does Medacta Group SA's (VTX:MOVE) Share Price Indicate?

Market Participants Recognise Medacta Group SA's (VTX:MOVE) Earnings Pushing Shares 26% Higher

May 10
Market Participants Recognise Medacta Group SA's (VTX:MOVE) Earnings Pushing Shares 26% Higher

Medacta Group SA's (VTX:MOVE) CEO Compensation Looks Acceptable To Us And Here's Why

May 01
Medacta Group SA's (VTX:MOVE) CEO Compensation Looks Acceptable To Us And Here's Why

Here's Why Medacta Group (VTX:MOVE) Can Manage Its Debt Responsibly

Apr 24
Here's Why Medacta Group (VTX:MOVE) Can Manage Its Debt Responsibly

Return Trends At Medacta Group (VTX:MOVE) Aren't Appealing

Apr 10
Return Trends At Medacta Group (VTX:MOVE) Aren't Appealing

Medacta Group SA (VTX:MOVE) Yearly Results: Here's What Analysts Are Forecasting For This Year

Mar 28
Medacta Group SA (VTX:MOVE) Yearly Results: Here's What Analysts Are Forecasting For This Year

Medacta Group SA (VTX:MOVE) Looks Just Right With A 25% Price Jump

Feb 13
Medacta Group SA (VTX:MOVE) Looks Just Right With A 25% Price Jump
User avatar

New Products Like GMK SpheriKA And NextAR Will Strengthen Future Prospects In The Spine Segment

Medacta's innovation in product launches and medical education expansion drives revenue growth, with a strong focus on the Spine segment and ASCs.

Returns On Capital Signal Tricky Times Ahead For Medacta Group (VTX:MOVE)

Jan 06
Returns On Capital Signal Tricky Times Ahead For Medacta Group (VTX:MOVE)

The Price Is Right For Medacta Group SA (VTX:MOVE)

Nov 22
The Price Is Right For Medacta Group SA (VTX:MOVE)

Is Medacta Group (VTX:MOVE) A Risky Investment?

Oct 14
Is Medacta Group (VTX:MOVE) A Risky Investment?

Medacta Group SA (VTX:MOVE) Shares Could Be 32% Above Their Intrinsic Value Estimate

Sep 06
Medacta Group SA (VTX:MOVE) Shares Could Be 32% Above Their Intrinsic Value Estimate

What Does Medacta Group SA's (VTX:MOVE) Share Price Indicate?

Aug 21
What Does Medacta Group SA's (VTX:MOVE) Share Price Indicate?

Medacta Group (VTX:MOVE) Is Reinvesting At Lower Rates Of Return

Aug 06
Medacta Group (VTX:MOVE) Is Reinvesting At Lower Rates Of Return

Medacta Group SA's (VTX:MOVE) P/E Still Appears To Be Reasonable

Jun 20
Medacta Group SA's (VTX:MOVE) P/E Still Appears To Be Reasonable

We Discuss Why Medacta Group SA's (VTX:MOVE) CEO Will Find It Hard To Get A Pay Rise From Shareholders This Year

May 01
We Discuss Why Medacta Group SA's (VTX:MOVE) CEO Will Find It Hard To Get A Pay Rise From Shareholders This Year

Medacta Group (VTX:MOVE) Has A Pretty Healthy Balance Sheet

Apr 17
Medacta Group (VTX:MOVE) Has A Pretty Healthy Balance Sheet

Is Now An Opportune Moment To Examine Medacta Group SA (VTX:MOVE)?

Mar 29
Is Now An Opportune Moment To Examine Medacta Group SA (VTX:MOVE)?

Does Medacta Group (VTX:MOVE) Deserve A Spot On Your Watchlist?

Feb 22
Does Medacta Group (VTX:MOVE) Deserve A Spot On Your Watchlist?

Medacta Group (VTX:MOVE) Will Be Hoping To Turn Its Returns On Capital Around

Feb 07
Medacta Group (VTX:MOVE) Will Be Hoping To Turn Its Returns On Capital Around

Getting In Cheap On Medacta Group SA (VTX:MOVE) Might Be Difficult

Dec 18
Getting In Cheap On Medacta Group SA (VTX:MOVE) Might Be Difficult

Calculating The Intrinsic Value Of Medacta Group SA (VTX:MOVE)

Dec 04
Calculating The Intrinsic Value Of Medacta Group SA (VTX:MOVE)

Is Now The Time To Look At Buying Medacta Group SA (VTX:MOVE)?

Nov 15
Is Now The Time To Look At Buying Medacta Group SA (VTX:MOVE)?

Returns On Capital Signal Tricky Times Ahead For Medacta Group (VTX:MOVE)

Oct 30
Returns On Capital Signal Tricky Times Ahead For Medacta Group (VTX:MOVE)

If EPS Growth Is Important To You, Medacta Group (VTX:MOVE) Presents An Opportunity

Oct 17
If EPS Growth Is Important To You, Medacta Group (VTX:MOVE) Presents An Opportunity

Is Medacta Group (VTX:MOVE) Using Too Much Debt?

Sep 29
Is Medacta Group (VTX:MOVE) Using Too Much Debt?

Calculating The Intrinsic Value Of Medacta Group SA (VTX:MOVE)

Aug 11
Calculating The Intrinsic Value Of Medacta Group SA (VTX:MOVE)

Is Now The Time To Look At Buying Medacta Group SA (VTX:MOVE)?

Jul 27
Is Now The Time To Look At Buying Medacta Group SA (VTX:MOVE)?

Be Wary Of Medacta Group (VTX:MOVE) And Its Returns On Capital

Jul 03
Be Wary Of Medacta Group (VTX:MOVE) And Its Returns On Capital

At CHF117, Is It Time To Put Medacta Group SA (VTX:MOVE) On Your Watch List?

Apr 28
At CHF117, Is It Time To Put Medacta Group SA (VTX:MOVE) On Your Watch List?

Is Medacta Group (VTX:MOVE) A Risky Investment?

Apr 08
Is Medacta Group (VTX:MOVE) A Risky Investment?

Is Now An Opportune Moment To Examine Medacta Group SA (VTX:MOVE)?

Dec 25
Is Now An Opportune Moment To Examine Medacta Group SA (VTX:MOVE)?

Capital Allocation Trends At Medacta Group (VTX:MOVE) Aren't Ideal

Dec 09
Capital Allocation Trends At Medacta Group (VTX:MOVE) Aren't Ideal

Does Medacta Group (VTX:MOVE) Have A Healthy Balance Sheet?

Nov 09
Does Medacta Group (VTX:MOVE) Have A Healthy Balance Sheet?

Why Medacta Group SA (VTX:MOVE) Could Be Worth Watching

Sep 16
Why Medacta Group SA (VTX:MOVE) Could Be Worth Watching

The Returns On Capital At Medacta Group (VTX:MOVE) Don't Inspire Confidence

Aug 20
The Returns On Capital At Medacta Group (VTX:MOVE) Don't Inspire Confidence

Here's Why Medacta Group (VTX:MOVE) Has Caught The Eye Of Investors

Jul 02
Here's Why Medacta Group (VTX:MOVE) Has Caught The Eye Of Investors

Should You Think About Buying Medacta Group SA (VTX:MOVE) Now?

May 28
Should You Think About Buying Medacta Group SA (VTX:MOVE) Now?

Medacta Group (VTX:MOVE) Is Reinvesting At Lower Rates Of Return

May 12
Medacta Group (VTX:MOVE) Is Reinvesting At Lower Rates Of Return

These 4 Measures Indicate That Medacta Group (VTX:MOVE) Is Using Debt Reasonably Well

Mar 31
These 4 Measures Indicate That Medacta Group (VTX:MOVE) Is Using Debt Reasonably Well

Does Medacta Group (VTX:MOVE) Deserve A Spot On Your Watchlist?

Mar 17
Does Medacta Group (VTX:MOVE) Deserve A Spot On Your Watchlist?

Capital Investments At Medacta Group (VTX:MOVE) Point To A Promising Future

Feb 07
Capital Investments At Medacta Group (VTX:MOVE) Point To A Promising Future

Should You Investigate Medacta Group SA (VTX:MOVE) At CHF133?

Dec 10
Should You Investigate Medacta Group SA (VTX:MOVE) At CHF133?

Medacta Group (VTX:MOVE) Knows How To Allocate Capital

Nov 05
Medacta Group (VTX:MOVE) Knows How To Allocate Capital

Here's Why Medacta Group (VTX:MOVE) Can Manage Its Debt Responsibly

Sep 30
Here's Why Medacta Group (VTX:MOVE) Can Manage Its Debt Responsibly

Is It Too Late To Consider Buying Medacta Group SA (VTX:MOVE)?

Aug 26
Is It Too Late To Consider Buying Medacta Group SA (VTX:MOVE)?

Medacta Group (VTX:MOVE) May Have Issues Allocating Its Capital

Jul 20
Medacta Group (VTX:MOVE) May Have Issues Allocating Its Capital

Should You Investigate Medacta Group SA (VTX:MOVE) At CHF119?

May 19
Should You Investigate Medacta Group SA (VTX:MOVE) At CHF119?

We Think Medacta Group (VTX:MOVE) Can Stay On Top Of Its Debt

Apr 05
We Think Medacta Group (VTX:MOVE) Can Stay On Top Of Its Debt

CEO報酬分析

Medacta Group の収益と比較して、Francesco Siccardi の報酬はどのように変化したか？
日付総報酬給与会社業績
Jun 30 2025n/an/a

€95m

Mar 31 2025n/an/a

€84m

Dec 31 2024€2m€392k

€73m

Sep 30 2024n/an/a

€65m

Jun 30 2024n/an/a

€56m

Mar 31 2024n/an/a

€52m

Dec 31 2023€2m€396k

€47m

Sep 30 2023n/an/a

€49m

Jun 30 2023n/an/a

€50m

Mar 31 2023n/an/a

€48m

Dec 31 2022€2m€372k

€46m

Sep 30 2022n/an/a

€47m

Jun 30 2022n/an/a

€47m

Mar 31 2022n/an/a

€49m

Dec 31 2021€2m€354k

€52m

Sep 30 2021n/an/a

€54m

Jun 30 2021n/an/a

€57m

Mar 31 2021n/an/a

€47m

Dec 31 2020€1m€339k

€37m

Sep 30 2020n/an/a

€24m

Jun 30 2020n/an/a

€10m

Mar 31 2020n/an/a

€11m

Dec 31 2019€843k€247k

€12m

報酬と市場: Francescoの 総報酬 ($USD 2.30M ) は、 Swiss市場 ($USD 1.70M ) の同規模の企業の平均を上回っています。

報酬と収益: Francescoの報酬は、過去 1 年間の会社の業績と一致しています。

CEO

Francesco Siccardi (48 yo)

7yrs
在職期間
€1,997,619
報酬

Dr. Francesco Siccardi has been Chief Executive Officer of Medacta Group SA since November 1, 2018. He is a Member of the Board of Directors of Surgical Practice Resource Group SA, Lugano since 2015 and of...

リーダーシップ・チーム

名称ポジション在職期間報酬所有権
Alberto Siccardi
Founder & Non Executive Chairman7.8yrs€346.42kデータなし
Francesco Siccardi
Chief Executive Officer7yrs€2.00mデータなし
Corrado Farsetta
Chief Financial Officer14.8yrsデータなしデータなし
Asif Hussain
Chief People Officerno dataデータなしデータなし
Alessandro Siccardi
Chief Supply Chain Officer9.8yrsデータなしデータなし
Filippo Cappelli
Head of ITno dataデータなしデータなし
Giovanni Galli
Chief Commercial Officerno dataデータなしデータなし
Massimiliano Bernardoni
Chief Innovation Officerno dataデータなしデータなし
Donato Cortesi
Secretary of the Boardno dataデータなしデータなし
Antonio Di Brino
Group Vice President of Finance & Taxno dataデータなしデータなし
12.3yrs
平均在職期間
52yo
平均年齢

経験豊富な経営陣: MOVEの経営陣は経験豊富で経験豊富です（平均在職期間は12.3年）。

取締役

名称ポジション在職期間報酬所有権
Alberto Siccardi
Founder & Non Executive Chairman7.8yrs€346.42kデータなし
Victor Balli
Lead Independent Director6.8yrs€228.29kデータなし
Riccardo Braglia
Independent Director4.9yrs€127.15kデータなし
Philippe Weber
Independent Director6.7yrs€150.26kデータなし
Maria Siccardi Tonolli
Non-executive Director7.8yrs€135.95kデータなし
6.8yrs
平均在職期間
65yo
平均年齢

経験豊富なボード: MOVEの 取締役会 は 経験豊富 であると考えられます ( 6.8年の平均在任期間)。

企業分析と財務データの現状

データ最終更新日（UTC時間）
企業分析2025/11/22 20:10
終値2025/11/21 00:00
収益2025/06/30
年間収益2024/12/31

データソース

企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。

パッケージデータタイムフレーム米国ソース例
会社財務10年
  • 損益計算書
  • キャッシュ・フロー計算書
  • 貸借対照表
アナリストのコンセンサス予想+プラス3年
  • 予想財務
  • アナリストの目標株価
市場価格30年
  • 株価
  • 配当、分割、措置
所有権10年
  • トップ株主
  • インサイダー取引
マネジメント10年
  • リーダーシップ・チーム
  • 取締役会
主な進展10年
  • 会社からのお知らせ

* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。

特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。

分析モデルとスノーフレーク

このレポートの作成に使用した分析モデルの詳細は、Githubページでご覧いただけます。また、レポートの使用方法に関するガイドや、Youtubeでのチュートリアルもご用意しています。

シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。

業界およびセクターの指標

私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。

アナリスト筋

Medacta Group SA 5 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。10

アナリスト機関
Samuel EnglandBerenberg
David AdlingtonJ.P. Morgan
Ilya BurganskyResearch Partners AG